Kookmin Bio
Kookmin Bio raised US$2.4M in Series B funding.
Email and contact information
Company website: kmbio.co.kr
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: , (South Korea)
Industry: Biotechnology
Business model:
Funding
- Total funding amount: $2,438,302 (in USD)
- Estimated valuation: $12,191,510.00
- Latest deal type: Series B
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK